Metformin Hydrochloride Recall

Indian pharmaceutical company Marksans Pharma Limited is recalling metformin hydrochloride extended-release tablets because their levels of NDMA (cancer-causing contaminant) were higher than the acceptable daily intake limit of 96 nanograms per day, according to a recall published this week by the US Food and Drug Administration (FDA).

https://www.cnn.com/2020/10/09/health/fda-recall-diabetes-medication-metformin-cancer-trnd/index.html